The OSSIX range of products are designed for clinical flexibility, ease of use, and solving common regenerative challenges. The OSSIX product family has enabled clinicians in hundreds of thousands of procedures spanning almost two decades to safely provide predictable, long-term results to their patients. Featuring the proprietary collagen cross-linking GLYMATRIX® technology, similar to the naturally occurring glycation process in the human body. The technology uses sugars to cross-link collagen molecules, producing a collagen matrix, which can be tailored to deliver products of varying physical properties and customised longevity.